Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAUL A BENSON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1174554364
CMS profile
53324
Location
BERKLEY, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$105,099.85

271 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 5 of 6; records 201–250 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAUL A BENSON

NPI 1174554364 · CMS profile ID 53324

Allopathic & Osteopathic Physicians / Family Medicine

BERKLEY, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 6; records 201–250 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174554364?year=2022&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAUL A BENSON, NPI 1174554364, CMS profile ID 53324. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 6; records 201–250 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174554364?year=2022&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). PAUL A BENSON, NPI 1174554364, CMS profile ID 53324. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 6; records 201–250 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174554364?year=2022&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
PAUL A BENSON, NPI 1174554364, CMS profile ID 53324, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 6; records 201–250 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1174554364?year=2022&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

271 matching records · $105,099.85 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 271 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 271.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $4.0404/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506451 CMS
Gilead Sciences, Inc. $13.8204/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506521 CMS
Janssen Biotech, Inc. $9.8804/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886021699 CMS
Janssen Biotech, Inc. $1.4404/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886021705 CMS
ViiV Healthcare Company $1.2104/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013429 CMS
Seqirus USA Inc $14.0104/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900641457 CMS
Novo Nordisk Inc $9.5204/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898908549 CMS
Novo Nordisk Inc $21.0004/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898810217 CMS
ViiV Healthcare Company $115.8904/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013419 CMS
Gilead Sciences, Inc. $18.6804/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506579 CMS
ViiV Healthcare Company $121.8604/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013445 CMS
Janssen Biotech, Inc. $12.8904/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886021770 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.9904/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955593397 CMS
ViiV Healthcare Company $8.3104/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013455 CMS
Gilead Sciences, Inc. $17.5004/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506559 CMS
ViiV Healthcare Company $119.7004/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013437 CMS
ViiV Healthcare Company $1,625.0004/05/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013307 CMS
Gilead Sciences, Inc. $2,080.0004/01/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929436779 CMS
Biohaven Pharmaceutical Holding Company Ltd. $15.1703/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923538881 CMS
Gilead Sciences, Inc. $100.0003/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506659 CMS
Janssen Biotech, Inc. $23.3003/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886021722 CMS
ViiV Healthcare Company $4.4603/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013405 CMS
ViiV Healthcare Company $3,900.0003/29/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013451 CMS
Theratechnologies Inc. $41.5803/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943967325 CMS
ViiV Healthcare Company $113.4003/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013289 CMS
Napo Pharmaceuticals Inc $21.8403/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951969051 CMS
Novo Nordisk Inc $121.4703/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898908567 CMS
ViiV Healthcare Company $8.8903/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013422 CMS
Gilead Sciences, Inc. $4.0003/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506447 CMS
Merck Sharp & Dohme LLC $23.2703/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944156197 CMS
Amarin Pharma Inc. $12.4603/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 913920425 CMS
Novo Nordisk Inc $13.3703/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898957381 CMS
Gilead Sciences, Inc. $6.3303/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506459 CMS
Gilead Sciences, Inc. $8.1203/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506463 CMS
Gilead Sciences, Inc. $0.6603/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506435 CMS
Gilead Sciences, Inc. $15.8003/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506537 CMS
Gilead Sciences, Inc. $8.7703/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506475 CMS
Janssen Biotech, Inc. $13.9103/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886021693 CMS
ViiV Healthcare Company $5,200.0003/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013389 CMS
Gilead Sciences, Inc. $1.8503/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506443 CMS
Gilead Sciences, Inc. $15.2103/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506529 CMS
Gilead Sciences, Inc. $2,080.0002/25/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929436773 CMS
Gilead Sciences, Inc. $12.0002/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929461919 CMS
Theratechnologies Inc. $19.4102/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943967319 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.7502/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955593395 CMS
Gilead Sciences, Inc. $97.2802/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506651 CMS
Biohaven Pharmaceutical Holding Company Ltd. $15.3702/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923538879 CMS
Gilead Sciences, Inc. $20.9502/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929506603 CMS
ViiV Healthcare Company $1.2602/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013415 CMS
ViiV Healthcare Company $3.2002/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944013475 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $184,615.85 415
PY2020 $53,440.23 236
PY2021 $78,315.80 307
PY2022 $105,099.85 271
PY2023 $113,149.61 281
PY2024 $110,592.46 257
PY2025 $133,713.33 221

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $232,069.14 30
PY2024 Principal investigator $226,984.63 27
PY2023 Recipient $2,403.32 9
PY2023 Principal investigator $256,218.90 29
PY2022 Principal investigator $283,441.86 41
PY2021 Principal investigator $578,689.70 76
PY2020 Principal investigator $826,413.08 81
PY2019 Recipient $3,055.23 25
PY2019 Principal investigator $971,288.31 110

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

30 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Gilead Sciences, Inc. $1,509.00 12/16/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217399
Principal investigator 1 ViiV Healthcare Company $10,736.10 11/19/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190315771
Principal investigator 1 ViiV Healthcare Company $1,206.00 11/19/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 3B, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY EVALUATING THE E No dispute reported 06/30/2026 1190318791
Principal investigator 1 Gilead Sciences, Inc. $1,372.00 11/18/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217390
Principal investigator 1 ViiV Healthcare Company $13,317.20 10/28/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190315875
Principal investigator 1 Gilead Sciences, Inc. $7,325.00 10/21/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217382
Principal investigator 1 ViiV Healthcare Company $11,162.66 09/23/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190315785
Principal investigator 1 Gilead Sciences, Inc. $3,040.00 09/16/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217373
Principal investigator 1 Gilead Sciences, Inc. $3,040.00 08/19/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217359
Principal investigator 1 ViiV Healthcare Company $15,261.92 08/15/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190318793
Principal investigator 1 Gilead Sciences, Inc. $9,026.00 07/22/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217349
Principal investigator 1 ViiV Healthcare Company $11,265.57 07/17/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190318789
Principal investigator 1 ViiV Healthcare Company $1,744.88 07/11/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE IIIB, MULTI-CENTER, NON-RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL No dispute reported 06/30/2026 1190315879
Principal investigator 1 ViiV Healthcare Company $1,905.75 07/09/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 3B, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY EVALUATING THE E No dispute reported 06/30/2026 1190315877
Principal investigator 1 Gilead Sciences, Inc. $2,482.00 06/17/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217338
Principal investigator 1 ViiV Healthcare Company $10,750.00 06/17/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
CAPTIVATE (CAB LA FOR PREP UTILIZATION OUTCOMES EXPERIENCE) No dispute reported 06/30/2026 1190315775
Principal investigator 1 ViiV Healthcare Company $17,408.34 06/13/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190315783
Principal investigator 1 ViiV Healthcare Company $25,063.26 05/26/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190315773
Principal investigator 1 Gilead Sciences, Inc. $3,180.00 05/20/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217330
Principal investigator 1 ViiV Healthcare Company $18,937.87 04/28/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190315779
Principal investigator 1 Gilead Sciences, Inc. $8,626.00 04/22/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217322
Principal investigator 1 ViiV Healthcare Company $1,842.50 04/09/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 3B, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY EVALUATING THE E No dispute reported 06/30/2026 1190315883
Principal investigator 1 ViiV Healthcare Company $11,551.62 04/09/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE IIIB, MULTI-CENTER, NON-RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL No dispute reported 06/30/2026 1190318795
Principal investigator 1 ViiV Healthcare Company $2,784.60 03/21/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190315781
Principal investigator 1 ViiV Healthcare Company $2,670.43 03/21/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190318797
Principal investigator 1 Gilead Sciences, Inc. $3,040.00 03/18/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217314
Principal investigator 1 Gilead Sciences, Inc. $8,910.00 02/19/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217306
Principal investigator 1 ViiV Healthcare Company $2,490.75 01/29/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE 3B, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY EVALUATING THE E No dispute reported 06/30/2026 1190315777
Principal investigator 1 ViiV Healthcare Company $11,178.69 01/29/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER
A PHASE IIIB, MULTI-CENTER, NON-RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL No dispute reported 06/30/2026 1190315881
Principal investigator 1 Gilead Sciences, Inc. $9,241.00 01/22/2025 Non-covered Recipient Entity
BE WELL MEDICAL CENTER PC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217293